Merck KGaA has struck a deal to buy U.S. biotech company SpringWorks Therapeutics for an equity value of $3.9 billion, as the ...

A genetic signature including four genes in gastric cancer is linked to an increase in recurrence and mortality.

German health care and science group Merck has sealed a deal to bolster its cancer treatment portfolio with a $3.9-billion ...